Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.
Publication
, Journal Article
Young, CC; Kaufman, BS
Published in: J Clin Anesth
December 1995
Neuroleptic malignant syndrome is a potentially fatal disorder that may develop in the perioperative period. A case is described in which discontinuation of chronic levodopa therapy precipitated the postoperative development of this syndrome. The differential diagnosis and management principles are reviewed.
Duke Scholars
Published In
J Clin Anesth
DOI
ISSN
0952-8180
Publication Date
December 1995
Volume
7
Issue
8
Start / End Page
652 / 656
Location
United States
Related Subject Headings
- Substance Withdrawal Syndrome
- Postoperative Complications
- Neuromuscular Blocking Agents
- Neuroleptic Malignant Syndrome
- Middle Aged
- Levodopa
- Humans
- Female
- Antiparkinson Agents
- Anesthesiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Young, C. C., & Kaufman, B. S. (1995). Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal. J Clin Anesth, 7(8), 652–656. https://doi.org/10.1016/0952-8180(95)00097-6
Young, C. C., and B. S. Kaufman. “Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.” J Clin Anesth 7, no. 8 (December 1995): 652–56. https://doi.org/10.1016/0952-8180(95)00097-6.
Young CC, Kaufman BS. Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal. J Clin Anesth. 1995 Dec;7(8):652–6.
Young, C. C., and B. S. Kaufman. “Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.” J Clin Anesth, vol. 7, no. 8, Dec. 1995, pp. 652–56. Pubmed, doi:10.1016/0952-8180(95)00097-6.
Young CC, Kaufman BS. Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal. J Clin Anesth. 1995 Dec;7(8):652–656.
Published In
J Clin Anesth
DOI
ISSN
0952-8180
Publication Date
December 1995
Volume
7
Issue
8
Start / End Page
652 / 656
Location
United States
Related Subject Headings
- Substance Withdrawal Syndrome
- Postoperative Complications
- Neuromuscular Blocking Agents
- Neuroleptic Malignant Syndrome
- Middle Aged
- Levodopa
- Humans
- Female
- Antiparkinson Agents
- Anesthesiology